Loading clinical trials...
Loading clinical trials...
Bayesian Phase II Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer
Conditions
Interventions
Modified Barium Swallow (MBS)
Swallowing Questionnaire
+5 more
Locations
1
United States
University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Start Date
January 17, 2018
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2026
Last Updated
December 17, 2025
NCT07209189
NCT06902623
NCT03093909
NCT05375266
NCT04432597
NCT03822897
Lead Sponsor
M.D. Anderson Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions